关键信息
-
基因名
STK32A
- 应用
-
别名
STK32A；YANK1；Serine/threonine-Protein kinase 32A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WU08
-
表达区间
1-166aa
-
氨基酸序列
MGANTSRKPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHDTWLSYKSH
-
分子量
46.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
STK32A is a member of the serine/threonine kinase family, which plays a crucial role in various cellular processes, including signal transduction, cell cycle regulation, and apoptosis. As a protein that is implicated in numerous biological functions, the study of STK32A and its recombinant form has garnered significant attention in the field of molecular biology and therapeutic research. Researchers have observed that STK32A may play a role in modulating inflammatory responses and cellular stress, making it a potential target for understanding diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. Recombinant STK32A proteins are being developed to further investigate its enzymatic activity, interaction with other cellular partners, and its impact on various signaling pathways. These studies aim to unravel the specific mechanisms by which STK32A contributes to cell behavior and identify its potential utility as a biomarker or therapeutic target. The generation of STK32A recombinant proteins allows for detailed biochemical analyses and functional assays, ultimately paving the way for novel approaches in disease treatment and diagnosis.
